Media/Press
Dr. Decotiis on WPTV 5 – Benefits & Concerns for Weight Loss Drugs Ozempic & Semaglutide
Dr. Decotiis on CBS News – Best Time to Workout & Lose Weight?
Dr. Decotiis on Pix 11 News – Explaining Hormones & Weight Gain: Why Ozempic and Mounjaro Work
Dr. Decotiis on Fox & Friends: Discussing Weight Loss Pills
Dr. Decotiis on NY1 – Are Popular Weight Loss Drugs Safe: Ozempic, Liraglutide, Saxenda, Mounjaro
Dr. Decotiis on Fox News – PFAs & Obesity. Forever Chemicals Causing Obesity
Dr. Decotiis on Fox News – Discussion on Mounjaro, Ozempic, Semaglutide, & Tirzepatide
Dr. Decotiis on Fox News – Mounjaro Benefits
Dr. Decotiis Contributes to TheMessenger – Zepbound vs. Wegovy: How the Weight Loss Drugs Differ
Zepbound — Eli Lilly’s latest weight management medication — received approval from the Food and Drug Administration this week for use in adults who are obese or are overweight with at least one weight-related condition. If Zepbound sounds familiar, that’s because it is: The base drug is tirzepatide, which is the same as Eli Lilly’s Mounjaro. The […]